Birgitta Nordgren1,2, Cecilia Fridén1,2, Ingrid Demmelmaier1,2, Gunnar Bergström1,2, Ingrid E Lundberg1,2, Thomas Nessen1,2, Alyssa B Dufour1,2, Christina H Opava. 1. From the Division of Physiotherapy, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge; Functional Area Occupational Therapy and Physiotherapy, Allied Health Professionals' Function, Karolinska University Hospital; Unit of Intervention and Implementation Research for Worker Health, Institute of Environmental Medicine, Karolinska Institutet; Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden; Harvard Medical School; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. 2. B. Nordgren, PhD; Division of Physiotherapy, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, and Functional Area Occupational Therapy and Physiotherapy, Allied Health Professionals' Function, Karolinska University Hospital; C. Fridén, Associate Professor, Division of Physiotherapy, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet; I. Demmelmaier, Associate Professor, Division of Physiotherapy, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet; G. Bergström, Associate Professor, Unit of Intervention and Implementation Research for Worker Health, Institute of Environmental Medicine, Karolinska Institutet; I.E. Lundberg, Professor, Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Solna, Karolinska Institutet; T. Nessen, PhD, Division of Physiotherapy, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet; A.B. Dufour, PhD, Division of Physiotherapy, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Harvard Medical School, and Beth Israel Deaconess Medical Center; C.H. Opava, Professor, Division of Physiotherapy, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, and Department of Rheumatology, Karolinska University Hospital.
Abstract
OBJECTIVE: To describe changes of health-enhancing physical activity (HEPA), health perception, and functioning during the second year of a 2-year support program, determine aspects of adherence and response, and describe perceptions of the program. METHODS: Out of 220 individuals with rheumatoid arthritis (RA), 177 participated in the followup. Group support, strength training, and moderate-intensity aerobic activity were encouraged. Data collection included HEPA, perceived health, functioning, and perceptions of the program. Participants with unchanged/improved general health perception and at least 2 of aerobic capacity, grip strength, or timed standing were considered responders. RESULTS: Current and maintained HEPA decreased from 82% to 75% (p = 0.0141) and from 41% to 27% (p < 0.0001) during the second year. Minor declines in quality of life and activity limitation occurred (p = 0.0395 and 0.0038, respectively), while outcome expectations for benefits of physical activity increased (p = 0.0010 and 0.0186) and waist circumference tapered off (p = 0.0070). Strength training was performed on average 41 and 35 times among responders (n = 54) and nonresponders (n = 105), respectively (p = 0.2708); HEPA 194 and 171 days, respectively (p = 0.0828); and support group meetings 12 and 10 times, respectively (p = 0.0943). Strength training, aerobic activity, and short text message reminders were perceived as most valuable; step registration and the self-monitoring walk tests were less appreciated. CONCLUSION: About one-fourth of the originally sedentary individuals with RA sustained their new HEPA behaviors after 2 years and most improvements of health and functioning were sustained. Structured use of behavior change techniques and a second year to support maintenance with a reduced program might help patients with RA to sustain HEPA behavior.
OBJECTIVE: To describe changes of health-enhancing physical activity (HEPA), health perception, and functioning during the second year of a 2-year support program, determine aspects of adherence and response, and describe perceptions of the program. METHODS: Out of 220 individuals with rheumatoid arthritis (RA), 177 participated in the followup. Group support, strength training, and moderate-intensity aerobic activity were encouraged. Data collection included HEPA, perceived health, functioning, and perceptions of the program. Participants with unchanged/improved general health perception and at least 2 of aerobic capacity, grip strength, or timed standing were considered responders. RESULTS: Current and maintained HEPA decreased from 82% to 75% (p = 0.0141) and from 41% to 27% (p < 0.0001) during the second year. Minor declines in quality of life and activity limitation occurred (p = 0.0395 and 0.0038, respectively), while outcome expectations for benefits of physical activity increased (p = 0.0010 and 0.0186) and waist circumference tapered off (p = 0.0070). Strength training was performed on average 41 and 35 times among responders (n = 54) and nonresponders (n = 105), respectively (p = 0.2708); HEPA 194 and 171 days, respectively (p = 0.0828); and support group meetings 12 and 10 times, respectively (p = 0.0943). Strength training, aerobic activity, and short text message reminders were perceived as most valuable; step registration and the self-monitoring walk tests were less appreciated. CONCLUSION: About one-fourth of the originally sedentary individuals with RA sustained their new HEPA behaviors after 2 years and most improvements of health and functioning were sustained. Structured use of behavior change techniques and a second year to support maintenance with a reduced program might help patients with RA to sustain HEPA behavior.
Entities:
Keywords:
CLINICAL TRIAL; EXERCISE; FOLLOWUP STUDY; HEALTH BEHAVIOR
Authors: Monika Löfgren; Christina H Opava; Ingrid Demmelmaier; Cecilia Fridén; Ingrid E Lundberg; Birgitta Nordgren; Eva Kosek Journal: Arthritis Res Ther Date: 2018-11-26 Impact factor: 5.156
Authors: Sally A M Fenton; Joan L Duda; Jet J C S Veldhuijzen van Zanten; George S Metsios; George D Kitas Journal: Mediterr J Rheumatol Date: 2020-03-31